QurAlis Corporation
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants (NCT07421778) | QurAlis Corporation | 2026-02-02 |
| A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants (NCT06877624) | QurAlis Corporation | 2025-01-10 |
| A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS (NCT06714396) | QurAlis Corporation | 2024-11-11 |
| A 3-way Cross-over Study on the Effects of QRL-101 on Transcranial Magnetic Stimulation and Nerve Excitability in Healthy Participants (NCT06681441) | QurAlis Corporation | 2024-10-07 |
| A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants (NCT06532396) | QurAlis Corporation | 2024-07-01 |
| A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants (NCT05667779) | QurAlis Corporation | 2022-12-22 |
| A Study Evaluating the Safety and Tolerability of QRL-201 in ALS (NCT05633459) | QurAlis Corporation | 2022-12-16 |
Track QurAlis Corporation automatically
Every clearance here is in the API, with alerts when new ones post.